In an industry where regulatory requirements vary from country to country, and where demand is increasingly fragmented across multiple product variants, late-stage customization has become a strategic tool for pharmaceutical manufacturers.

Late-stage customization is the practice of producing packaging in a neutral form and only applying market-specific information when an actual order is placed. This approach enables manufacturers to postpone the final packaging step – such as printing, labeling, or applying artwork – until the latest possible moment in the process. The result: increased flexibility, reduced inventory, and faster time to market.

A packaging strategy for a changing industry

Late-stage customization can be applied across a wide range of packaging formats:

• Blister packs, where sealed blisters are printed on-demand
• Bottles and vials, where labels are printed and applied just before shipping
• Folding cartons, where variable data or market-specific codes are printed inline
• Pouches or sachets, where neutral materials are customized per order
• Secondary packaging, where different languages, patient instructions, or branding requirements apply

What all these applications have in common is the ability to decouple the physical packaging process from the final market adaptation. This gives companies far greater agility in how they serve different regions and product segments.

Late-stage customization in blister packaging

One of the clearest use cases of late-stage customization is blister packaging, particularly in production setups with high product variability and small batch sizes. By producing sealed, unprinted blisters at high speed and applying all required information at the final step, manufacturers gain full flexibility to manage market demand without compromising GMP compliance or artwork traceability.

For example, a single pharmaceutical product available in three strengths and sold in 40 countries could otherwise require 120 individual blister variants. With late-stage customization, the same neutral blister format can serve all 120 variants, drastically simplifying logistics and reducing cost per unit.

Strategic benefits for CMOs and CDMOs

For contract manufacturing and packaging organizations (CMOs/CDMOs), late-stage customization can be a key differentiator. Clients increasingly expect faster turnaround times, more variants, and full compliance with serialization and traceability requirements.

Being able to offer packaging on-demand – whether through digital printing, print & apply, or inline coding – allows service providers to meet these expectations and build long-term strategic partnerships with pharmaceutical brands.

Is late-stage customization right for every setup?

Not necessarily. For large batches of stable products with minimal variation, traditional pre-printed materials or inline printing may still be the most cost-effective option.

However, for:

• Personalized medicine and niche treatments
• Market-specific branding or language versions
• Variable regulatory or patient information
• Agile supply chains with rapid market switching

… late-stage customization is often the most effective and future-proof approach.

Want to explore the potential in your packaging operations?

At PPS, we help pharmaceutical companies and contract manufacturers design packaging solutions that balance flexibility, compliance, and operational efficiency. Whether your focus is on blister printing, label customization, or automated late-stage processes, we support you in selecting and integrating the right technology.

Let’s discuss how late-stage customization can support your production strategy.

👉 Contact our specialists here
👉 Or explore our printing & labeling solutions